Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Comparison of Cumulative Live Birth Rate (CLBR) According to Patient Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) Stratification Among Low Prognosis Women Undergoing IVF-ICSI Cycles

Authors
Reeta Bansiwal 1
Reeta Mahey 1
Neena Malhotra 1
Neeta Singh 1
Monika Saini 1
Ashok Bhatt 1
Nilima Nilima 2
Kalaivani Mani 2
Rohitha Cheluvaraju 1
Monika Rajput 1
Neerja Bhatla 1
1 Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, India
2 Department of Biostatistics, All India Institute of Medical Sciences (AIIMS), New Delhi, India
10.18502/jri.v24i2.12497
Abstract
Background: The purpose of the current study was to evaluate patient-oriented strategies encompassing individualized oocyte number (POSEIDON) criteria, validate stratification of low prognosis women, and prognosticate their reproductive potential in terms of cumulative live birth rate (CLBR) in Indian women. Methods: Out of 4048 women who underwent IVF/ICSI, 3287 women met the criteria for final evaluation of CLBR. They criteria were divided into (a) group 1a as cases with <4 oocytes retrieved and 1b with 4-9 oocytes retrieved; (b) group 2a as cases with <4 oocytes retrieved and 2b with 4-9 oocytes retrieved; (c) group 3 (<35 years, AMH <1.2 ng/ml, AFC <5); and (d) group 4 (≥35 years, AMH <1.2 ng/ml, AFC <5). Non-POSEIDON group was sub-divided into normo-responders (10-20 oocytes) and hyper-responder (>20 oocytes). Results: Overall CLBR was two-fold lower in POSEIDON group as compared to non-POSEIDON group (p<0.001). For every one-year increase in the age, the odds of CLBR decreased by 4% (OR 0.96, CI 0.93-0.99) in POSEIDON group and by 5% (OR 0.95, CI 0.92-0.98) in non-POSEIDON group. For every unit increase in number of oocytes retrieved, the odds of CLBR increased by 1.22 times (OR1.22, CI 1.16-1.28) in POSEIDON group and by 1.08 times (OR 1.08, CI 1.05-1.11) in non-POSEIDON group. Among POSEIDON groups, the highest values in CLBR belonged to group 1b followed by 3, 2b, 4, 1a, and 2a. Conclusion: POSEIDON stratification of low-prognosis women undergoing IVF may be considered valid to prognosticate and counsel women undergoing IVF. Prospective studies will strengthen its validity among different ethnic populations.
Keywords
Cumulative live birth rate
Infertility
IVF
Low prognosis women
POSEIDON criteria
  1. Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616-24.
  2. Cohen J, Chabbert-Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder–a plea for universal definitions. J Assist Reprod Genet. 2015;32(12):1709-12.
  3. Poseidon group (Patient-oriented strategies encompassing individualizeD oocyte number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452-3.
  4. Esteves SC, Conforti A, Sunkara SK, Carbone L, Picarelli S, Vaiarelli A, et al. Improving reporting of clinical studies using the POSEIDON criteria: POSORT guidelines. Front Endocrinol (Lausanne). 2021;12:587051.
  5. Esteves SC, Roque M, Sunkara SK, Conforti A, Ubaldi FM, Humaidan P, et al. Oocyte quantity, as well as oocyte quality, plays a significant role for the cumulative live birth rate of a POSEIDON criteria patient. Hum Reprod. 2019;34(12):2555-7.
  6. Yang R, Zhang C, Chen L, Wang Y, Li R, Liu P, et al. Cumulative live birth rate of low prognosis patients with POSEIDON stratification: a single-centre data analysis. Reprod Biomed Online. 2020;41(5):834-44.
  7. Kotdawala AP, Mir P, Herrero J, Khajuria R, Lalit Kumar PGL, Banker MR. Embryonic aneuploidy after preimplantation genetic screening: age- and indication-matched comparative study between Indian and Spanish population. J Hum Reprod Sci. 2019;12 (2):141-9.
  8. Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270-83.
  9. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73(6):1155-8.
  10. Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. 2017. The international glossary on infertility and fertility care, 2017. Hum Reprod. 2017;32(9):1786-801.
  11. Ji J, Liu Y, Tong XH, Luo L, Ma J, Chen Z. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China. Hum Reprod. 2013;28(10):2728-34.
  12. McLernon DJ, Steyerberg EW, Te Velde ER, Lee AJ, Bhattacharya S. Predicting the chances of a live birth after one or more complete cycles of in vitro fertilisation: population-based study of linked cycle data from 113,873 women. BMJ. 2016;355:i5735.
  13. Vargas-Tominaga L, Vargas A, Alarc F, Medina A, Mez MG, Bejar K. Cumulative live birth rates of patients in the Peruvian Andes according to the POSEIDON criteria: a single-center retrospective analysis. JBRA Assist Reprod. 2021;25(3):412-6.
  14. Lean SC, Derricott H, Jones RL, Heazell AEP. Advanced maternal age and adverse pregnancy outcomes: a systematic review and meta-analysis. PLoS One. 2017;12(10):e0186287.
  15. Shan D, Qiu PY, Wu YX, Chen Q, Li AL, Ramadoss S, et al. Pregnancy outcomes in women of advanced maternal age: a retrospective cohort study from China. Sci Rep. 2018;8(1):12239.
  16. Shi W, Zhou H, Tian L, Zhao Z, Zhang W, Shi J. Cumulative live birth rates of good and low prognosis patients according to POSEIDON criteria: a single center analysis of 18,455 treatment cycles. Front Endocrinol (Lausanne). 2019;10;10:409.
  17. Leijdekkers JA, Eijkemans MJC, Tilborg TC, Oudshoorn SC, Golde RJT, Hoek A, et al. Cumulative live birth rates in low-prognosis women. Hum Reprod. 2019;34(6):1030-41.
Journal of Reproduction & Infertility
Volume 24, Issue 2
Spring 2023
Pages 117-131